Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,084 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Follow-Up Questions
Qui est le CEO de Almirall SA ?
Mr. Carlos Gallardo Pique est le Executive Chairman of the Board de Almirall SA, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action LBTSF ?
Le prix actuel de LBTSF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Almirall SA ?
Almirall SA appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Almirall SA ?
La capitalisation boursière actuelle de Almirall SA est de $0
Est-ce que Almirall SA est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 15 analystes ont établi des notations d'analystes pour Almirall SA, y compris 3 achat fort, 9 achat, 3 maintien, 0 vente et 3 vente forte
